Shingles may trigger dementia: study probes hidden danger
NCT ID NCT06903078
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This observational study looks at whether people with shingles (herpes zoster) have a higher risk of vascular dementia—memory loss from reduced blood flow to the brain. Researchers will analyze tiny particles called exosomes in blood samples from 375 participants over 12 months. No treatment is given; the goal is to understand the connection.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal biological links between shingles and vascular dementia, pointing toward future prevention strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It cannot prove cause and effect, and results may not lead to direct medical changes.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HERPES ZOSTER (HZ) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Email: •••••@•••••
Locations
-
Center for Clinical Studies, LTD. LLP
RECRUITINGHouston, Texas, 77004, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
-
Center for Clinical Studies, LTD. LLP
RECRUITINGWebster, Texas, 77598, United States
Contact Email: •••••@•••••
Contact Email: •••••@•••••
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a brain disease change behavior years before diagnosis?
- Can tracking thousands of dementia cases reshape how we care for patients?
- Brain scans track Alzheimer's clues over decades
- Dementia agitation drug trial halted after just 5 patients
- Alzheimer's drug trial pulled before it even started
- Touchscreen device aims to give voice to dementia patients